Skip to main content
Clinical Trials/NCT03550469
NCT03550469TerminatedNot Applicable

Weaning Oxygen Therapy With Model-based Adaptive Control

Stanford University2 sites in 1 country31 target enrollmentStarted: November 2, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
31
Locations
2
Primary Endpoint
Duration of hyperoxia

Study Overview

Brief Summary

The study is designed to evaluate the feasibility, safety and clinical utility of using an adaptive model to wean oxygen by computer assistance. Investigators hypothesize that weaning oxygen using this model will decrease duration of exposure to hyperoxia, decrease duration of exposure to hypoxia, decrease exposure to increased oxygen requirement, and decrease the number of manual fraction of inspired oxygen (FiO2) adjustments as compared to manual weaning of oxygen therapy.

Detailed Description

Investigators will perform a feasibility study followed by a randomized, controlled study on critically ill neonatal and pediatric patients on oxygen therapy.

Investigators will use a model-based adaptive control architecture to regulate FiO2 settings. A major advantage of using an "adaptive" control system is that the response of the patient to previous FiO2 settings are used to recompute the most appropriate FiO2 setting in fixed time intervals. As a result of this iterative and self-correcting process, the FiO2 value converges to the most appropriate value over a period of time.

Study Population:

Children <18 years of age admitted to the pediatric intensive care unit requiring oxygen therapy.

Study Design:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
— to 2 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 0 to 2 years of age
  • Admission to pediatric intensive care unit
  • Oxygen therapy with FiO2 >0.21 via high flow nasal cannula >4 litres per minute (LPM) oxygen or via mechanical ventilation

Exclusion Criteria

  • No supplemental oxygen requirement or less than 4 LPM oxygen by nasal cannula
  • Congenital cardiac disease
  • Pulmonary hypertension
  • Hemodynamic instability requiring intervention
  • Respiratory status deemed too tenuous for weaning by attending physician
  • Ward of the state

Outcomes

Primary Outcomes

Duration of hyperoxia

Time Frame: Entire study (anticipated as 2 years).

Duration of time patients exposed to hyperoxia

Secondary Outcomes

  • Oxygen saturation in target range(Entire study (anticipated as 2 years).)
  • Increased oxygen requirement(Entire study (anticipated as 2 years).)
  • Time of increased oxygen requirement(Entire study (anticipated as 2 years).)
  • Hypoxia incidence(Entire study (anticipated as 2 years).)
  • Duration of hypoxia(Entire study (anticipated as 2 years).)
  • Manual adjustments(Entire study (anticipated as 2 years).)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Azadeh Fayazi

Clinical Assistant Professor

Stanford University

Study Sites (2)

Loading locations...

Similar Trials

Computer-assisted Oxygen Therapy Weaning... | Clinical Trial